Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2026-08-03), Corporativo FraguaB de CV's 12-1 Month Momentum % is 1.17%.
The industry rank for Corporativo FraguaB de CV's 12-1 Month Momentum % or its related term are showing as below:
CGSBF's 12-1 Month Momentum % is ranked worse than 57.27% of 660
companies
in the Healthcare Providers & Services industry
Industry Median: -12.5
vs CGSBF: 1.17
Corporativo FraguaB de CV (OTCPK:CGSBF) 12-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Corporativo FraguaB de CV 12-1 Month Momentum % Related Terms
Corporativo FraguaB de CV 12-1 Month Momentum % Competitor Comparison
For the Pharmaceutical Retailers subindustry, Corporativo FraguaB de CV's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Corporativo FraguaB de CV 12-1 Month Momentum % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Corporativo FraguaB de CV's 12-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Corporativo FraguaB de CV's 12-1 Month Momentum % falls into.
Corporativo FraguaB de CV (OTCPK:CGSBF) 12-1 Month Momentum % Calculation
12-1 Month Momentum % is calculated as following:
12-1 Month Momentum %
=
( Price 1-month ago
/
Price 12-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Corporativo FraguaB de CV (CGSBF) has a 12-1 Month Momentum % of 1.17% as of Aug. 03, 2026. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on Corporativo FraguaB de CV and its competitors. According to the industry distribution chart, Corporativo FraguaB de CV ranks #378 out of 660 companies in the Healthcare Providers & Services industry, placing it in the top 57.3%.
Is Corporativo FraguaB de CV's 12-1 Month Momentum % too high?
Corporativo FraguaB de CV's current 12-1 Month Momentum % is 1.17%. Based on the distribution chart, Corporativo FraguaB de CV ranks #378 out of 660 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Corporativo FraguaB de CV has a GF Score™ of 91/100, reflecting its overall financial health beyond just this single metric.
How does Corporativo FraguaB de CV's 12-1 Month Momentum % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Corporativo FraguaB de CV ranks #378 out of 660 companies for 12-1 Month Momentum %. This places Corporativo FraguaB de CV in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 12-1 Month Momentum % for a Healthcare Providers & Services company?
A good 12-1 Month Momentum % depends on the Healthcare Providers & Services industry context. However, 12-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 12-1 Month Momentum % mean?
A high 12-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on Corporativo FraguaB de CV and its competitors. Corporativo FraguaB de CV's current 12-1 Month Momentum % is 1.17%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Corporativo FraguaB de CV stock overvalued right now?
Corporativo FraguaB de CV (CGSBF) has a current 12-1 Month Momentum % of 1.17%. The stock's GF Value™ is $43.12, compared to a current price of $29.66 — trading 31.2% below its estimated fair value. The current 12-1 Month Momentum % is 1.17%. Corporativo FraguaB de CV's overall GF Score™ is 91/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 12-1 Month Momentum % calculated?
12-1 Month Momentum % is calculated from a company's financial statements. For Corporativo FraguaB de CV (CGSBF), the current 12-1 Month Momentum % is 1.17% as of Aug. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Corporativo FraguaB de CV (CGSBF) Overvalued in 2026?
Based on GuruFocus' analysis, Corporativo FraguaB de CV stock appears to be undervalued.
The current stock price of $29.66 is trading 31.2% below its estimated GF Value™ of $43.12.
Key valuation signals for CGSBF:
12-1 Month Momentum %: 1.17%
GF Value™: $43.12 vs. price of $29.66 (31.2% below fair value)
No single metric tells the full story. See the CGSBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Corporativo Fragua SAB de CV is engaged in the drug retail sector in Mexico. The company operates a network of pharmacies under the SuperFarmacia brand name, focusing on selling medicines, medical devices, and a variety of other products, including grocery items, exercise machines, perfumes, housewares, electronics, personal care products, toys, and photographic equipment.
91GF Score
Get the complete analysis for CGSBF
12-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CGSBF has been successfully added to your 
